|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-10-18
|
|
pubmed:abstractText |
Anti-CD11a (hu1124) is a humanized monoclonal antibody directed against the CD11a subunit of LFA-1. This study investigated whether treatment with anti-CD11a antibody provides clinical benefit to patients with moderate to severe plaque psoriasis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0190-9622
|
|
pubmed:author |
pubmed-author:BauerRR,
pubmed-author:BissonnetteRR,
pubmed-author:CIDJ MJM,
pubmed-author:CareyWW,
pubmed-author:DedrickR LRL,
pubmed-author:GarovoyM RMR,
pubmed-author:GrattonDD,
pubmed-author:GulliverW PWP,
pubmed-author:HügelHH,
pubmed-author:KramerSS,
pubmed-author:KruegerJ GJG,
pubmed-author:LyndeC WCW,
pubmed-author:MinierDD,
pubmed-author:OuelletJ PJP,
pubmed-author:PappKK,
pubmed-author:PaterJJ,
pubmed-author:ShapiroJJ,
pubmed-author:ShearN HNH,
pubmed-author:WUL JLJ,
pubmed-author:WalickaTT,
pubmed-author:WhiteMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
665-74
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11606914-Adult,
pubmed-meshheading:11606914-Aged,
pubmed-meshheading:11606914-Antibodies, Monoclonal,
pubmed-meshheading:11606914-Double-Blind Method,
pubmed-meshheading:11606914-Female,
pubmed-meshheading:11606914-Humans,
pubmed-meshheading:11606914-Infusions, Intravenous,
pubmed-meshheading:11606914-Leukocyte Count,
pubmed-meshheading:11606914-Lymphocyte Count,
pubmed-meshheading:11606914-Lymphocyte Function-Associated Antigen-1,
pubmed-meshheading:11606914-Male,
pubmed-meshheading:11606914-Middle Aged,
pubmed-meshheading:11606914-Psoriasis,
pubmed-meshheading:11606914-Severity of Illness Index,
pubmed-meshheading:11606914-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody.
|
|
pubmed:affiliation |
Probity Medical Research, 30 Union St. East, Waterloo, Ontario N2J 1B7, Canada. kapapp@probitymedical.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
